October 31, 2025

Vir Biotechnology, Inc. (VIR) Stock Analysis: Exploring a Potential 190% Upside

Vir Biotechnology, Inc. (NASDAQ: VIR), a prominent player in the biotechnology sector, has carved out a niche in the healthcare landscape by focusing on the development..

ArriVent BioPharma, Inc. (AVBP) Stock Analysis: A Promising Biotech with 114% Potential Upside

ArriVent BioPharma, Inc. (NASDAQ: AVBP) stands out in the biotechnology industry, not only for its cutting-edge cancer therapies but also for its compelling investment potential. With..

Akebia Therapeutics, Inc. (AKBA) Stock Analysis: Exploring a Potential 223.81% Upside

For investors eyeing opportunities in the healthcare sector, Akebia Therapeutics, Inc. (NASDAQ: AKBA) presents a compelling case with its focus on innovative therapies for kidney diseases...

AMN Healthcare Services Inc (AMN): Investor Outlook Amidst Challenging Valuation and Growth Metrics

AMN Healthcare Services Inc (NYSE: AMN) navigates a complex landscape in the healthcare sector, offering a variety of technology-enabled workforce solutions and staffing services essential for..

GH Research PLC (GHRS) Investor Outlook: Biotech Stock Poised for 147.96% Upside Potential

GH Research PLC (NASDAQ: GHRS), a clinical-stage biopharmaceutical company based in Dublin, Ireland, is making waves in the biotechnology sector with its focus on innovative treatments..

Day One Biopharmaceuticals, Inc. (DAWN) Stock Analysis: Unraveling a Potential 234.60% Upside in the Biotech Arena

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) is capturing investor attention with a notable potential upside of 234.60%, as the company positions itself on the cutting edge..

Nuvation Bio Inc. (NUVB) Stock Analysis: Biotechnology Innovator with 58.58% Potential Upside

Nuvation Bio Inc. (NUVB), a clinical-stage biopharmaceutical company based in New York, is capturing investor attention with its promising oncology pipeline and significant potential upside. Trading..

uniQure N.V. (QURE) Stock Analysis: A Closer Look at Its 9.79% Potential Upside and Robust Pipeline

Investors eyeing the biotechnology sector may find uniQure N.V. (QURE), a leading player in the gene therapy space, an intriguing opportunity. With a market capitalization of..

STAAR Surgical Company (STAA) Stock Analysis: Navigating the Healthcare Sector with a 186.83 Forward P/E

STAAR Surgical Company (NASDAQ: STAA) stands as a noteworthy entity in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization..

Delcath Systems, Inc. (DCTH) Stock Analysis: Major Upside Potential with a 150% Target Price Surge

For investors keen on tapping into the healthcare sector, Delcath Systems, Inc. (NASDAQ: DCTH) presents an intriguing opportunity. With a focus on innovative treatments for liver..

Immunome, Inc. (IMNM) Stock Analysis: Unpacking a 50% Potential Upside in Biotech

Immunome, Inc. (NASDAQ: IMNM) is capturing the attention of investors in the healthcare sector with its promising biotech developments and the potential for significant stock appreciation...

CeriBell, Inc. (CBLL) Stock Analysis: A 151% Potential Upside in the Healthcare Sector

CeriBell, Inc. (CBLL), a promising player in the healthcare sector, is capturing investor attention with its innovative approach to neurological care. The company, headquartered in Sunnyvale,..

Markets step into shifting terrain with unexpected forces at work

The world’s equity markets have lifted to fresh highs as signs of easing inflation across major economies intersect with tentative breakthroughs in trade diplomacy. In the..

Praxis Precision Medicines, Inc (PRAX) Stock Analysis: A High-Stakes Biotech with 43% Upside Potential

Praxis Precision Medicines, Inc. (PRAX) is gaining attention in the biotechnology sector, particularly among investors with a keen interest in companies developing breakthrough therapies for central..

Xeris Biopharma Holdings, Inc. (XERS) Stock Analysis: Navigating the Biotech Waters with a 48.8% Revenue Boost

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) has been making waves in the biotechnology industry with its innovative approach to addressing chronic endocrine and neurological diseases. Headquartered..

Cronos Group Inc. (CRON) Stock Analysis: Navigating a 20.5% Revenue Growth Amidst Market Challenges

Cronos Group Inc. (NASDAQ: CRON), a prominent player in the cannabinoid sector, is capturing investor attention with its noteworthy 20.5% revenue growth, despite facing a complex..

Arcus Biosciences, Inc. (RCUS) Stock Analysis: A Potential 56.69% Upside in the Biotech Arena

Arcus Biosciences, Inc. (NASDAQ: RCUS) is making waves in the biotechnology sector with its promising portfolio of cancer therapies. As a clinical-stage biopharmaceutical company, Arcus is..

Syndax Pharmaceuticals, Inc. (SNDX) Investor Outlook: A Potential 186% Upside on Promising Cancer Therapies

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) stands out in the biotechnology sector with a compelling growth narrative, particularly for investors seeking exposure to innovative cancer treatments. With..

Zymeworks Inc. (ZYME) Stock Analysis: Biotechnology Innovator with a 27.9% Potential Upside

Zymeworks Inc. (NASDAQ: ZYME), a burgeoning player in the biotechnology sector, has caught the attention of investors with its promising therapeutic platforms and partnerships. With a..

CareDx, Inc. (CDNA) Stock Analysis: Uncovering a Potential 50.89% Upside in the Diagnostics Sector

As the healthcare landscape continues to evolve, CareDx, Inc. (NASDAQ: CDNA) stands out within the diagnostics and research industry. With a market capitalization of $770.19 million,..

Search

Funds

October 31, 2025

Search

Funds

October 31, 2025

FTSE 100

Funds